0001815849-24-000011.txt : 20240315 0001815849-24-000011.hdr.sgml : 20240315 20240315160426 ACCESSION NUMBER: 0001815849-24-000011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240312 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ATI Physical Therapy, Inc. CENTRAL INDEX KEY: 0001815849 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 851408039 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39439 FILM NUMBER: 24754649 BUSINESS ADDRESS: STREET 1: 790 REMINGTON BOULEVARD CITY: BOILINGBROOK STATE: IL ZIP: 60440 BUSINESS PHONE: 630-296-2223 MAIL ADDRESS: STREET 1: 790 REMINGTON BOULEVARD CITY: BOILINGBROOK STATE: IL ZIP: 60440 FORMER COMPANY: FORMER CONFORMED NAME: Fortress Value Acquisition Corp. II DATE OF NAME CHANGE: 20200622 8-K 1 ati-20240312.htm 8-K ati-20240312
false000181584900018158492024-03-122024-03-120001815849us-gaap:CommonClassAMember2024-03-122024-03-120001815849us-gaap:WarrantMember2024-03-122024-03-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): March 12, 2024
___________________________________
ATI Physical Therapy, Inc.
(Exact name of registrant as specified in its charter)
___________________________________
Delaware
(State or other jurisdiction of
incorporation or organization)
001-39439
(Commission File Number)
85-1408039
(I.R.S. Employer Identification Number)
790 Remington Boulevard
Bolingbrook, IL 60440
(Address of principal executive offices and zip code)
(630) 296-2223
(Registrant's telephone number, including area code)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Class A common stock, par value $0.0001ATIPNew York Stock Exchange
Redeemable Warrants, exercisable for Class A common stock at an exercise price of $575.00 per shareATIPWOTC Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company    ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On March 12, 2024, Brent Rhodes provided notice to ATI Physical Therapy, Inc. (the “Company”) that he will resign from his position as Chief Accounting Officer of the Company effective as of the end of business on March 28, 2024 (the “Effective Date”). Mr. Rhodes is resigning to pursue other opportunities. Mr. Rhodes’ resignation is not the result of a disagreement with the Company or the Company’s Board of Directors or of any matter relating to the Company’s operations, financial statements, policies or practices. The Company thanks Mr. Rhodes for his dedicated services and wishes him well in his future endeavors.

As of the Effective Date, Joseph Jordan, the Company’s Chief Financial Officer, will serve as the Company’s principal financial officer and principal accounting officer.




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 15th day of March, 2024.


ATI PHYSICAL THERAPY, INC.
By:
/s/ Joseph Jordan
Name:
Joseph Jordan
Title:
Chief Financial Officer



 EX-101.SCH 2 ati-20240312.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 ati-20240312_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 ati-20240312_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Period End Date Document Period End Date Class of Stock [Domain] Class of Stock [Domain] Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Document Information [Line Items] Document Information [Line Items] Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Warrant Warrant [Member] Entity Emerging Growth Company Entity Emerging Growth Company Common Class A Common Class A [Member] Document Type Document Type Amendment Flag Amendment Flag Class of Stock [Axis] Class of Stock [Axis] Document Information [Table] Document Information [Table] Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 5 ati-20240312_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Mar. 12, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Mar. 12, 2024
Entity Registrant Name ATI Physical Therapy, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39439
Entity Tax Identification Number 85-1408039
Entity Address, Postal Zip Code 60440
Entity Address, State or Province IL
Entity Address, City or Town Bolingbrook
Entity Address, Address Line One 790 Remington Boulevard
Local Phone Number 296-2223
City Area Code 630
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Document Information [Line Items]  
Amendment Flag false
Entity Central Index Key 0001815849
Common Class A  
Document Information [Line Items]  
Title of 12(b) Security Class A common stock, par value $0.0001
Trading Symbol ATIP
Security Exchange Name NYSE
Warrant  
Document Information [Line Items]  
Title of 12(b) Security Redeemable Warrants, exercisable for Class A common stock at an exercise price of $575.00 per share
Trading Symbol ATIPW
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 3 22 1 false 2 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://atiphysicaltherapy.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ati-20240312.htm ati-20240312.xsd ati-20240312_def.xml ati-20240312_lab.xml ati-20240312_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ati-20240312.htm": { "nsprefix": "ati", "nsuri": "http://atiphysicaltherapy.com/20240312", "dts": { "inline": { "local": [ "ati-20240312.htm" ] }, "schema": { "local": [ "ati-20240312.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "ati-20240312_def.xml" ] }, "labelLink": { "local": [ "ati-20240312_lab.xml" ] }, "presentationLink": { "local": [ "ati-20240312_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://atiphysicaltherapy.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ati-20240312.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ati-20240312.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Common Class A", "label": "Common Class A [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant", "label": "Warrant [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001815849-24-000011-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001815849-24-000011-xbrl.zip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�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end XML 16 ati-20240312_htm.xml IDEA: XBRL DOCUMENT 0001815849 2024-03-12 2024-03-12 0001815849 us-gaap:CommonClassAMember 2024-03-12 2024-03-12 0001815849 us-gaap:WarrantMember 2024-03-12 2024-03-12 false 0001815849 8-K 2024-03-12 ATI Physical Therapy, Inc. DE 001-39439 85-1408039 790 Remington Boulevard Bolingbrook IL 60440 630 296-2223 false false false false Class A common stock, par value $0.0001 ATIP NYSE Redeemable Warrants, exercisable for Class A common stock at an exercise price of $575.00 per share ATIPW false